Skip to content

Pathogenic Bordetella Rapid Detection

Establishment a Nucleic Acid Rapid Detection Technology Platform for Detecting Pathogenic Bordetella and Its Drug Resistance Genes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037764
Enrollment
Unknown
Registered
2020-08-31
Start date
2021-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Interventions

Gold Standard:Bordetella isolation culture and identification method is the gold standard,the MIC drug sensitivity test method is the reference standard, and the registered Bordetella pertussis fluore
Index test:the&#32
CPA&#32
based&#32
on&#32
CRISPR&#32
technology

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Patients with continuous cough (paroxysmal cough) for more than 1 week, peripheral white blood cell 18x10^9/L (infants and young children), or> 15x10^9/L (children), ineffective use of cephalosporin antibacterial drugsand these patients whose nasopharyngeal swabs are collected for routine bordetella culture identification and drug susceptibility testing would be included as research object.

Exclusion criteria

Exclusion criteria: Patients with pertussis are suspected clinically but no nasopharyngeal swab specimens are collected or patients with pertussis are clinically excluded.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;

Countries

China

Contacts

Public ContactChuanqing Wang

Children's Hospital of Fudan University

Chuanqing523@163.com+86 18017591167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026